Variant report
Variant | nsv999490 |
---|---|
Chromosome Location | chr1:105105338-105173095 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549083896 | chr1:105108805-105108806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557598545 | chr1:105108811-105108812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs534721969 | chr1:105108816-105108817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs367903073 | chr1:105108840-105108841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150092708 | chr1:105108843-105108844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147155878 | chr1:105108845-105108846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2037113 | chr1:105108865-105108866 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs2037114 | chr1:105108885-105108886 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs72687444 | chr1:105108893-105108894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141239178 | chr1:105108913-105108914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374979277 | chr1:105108914-105108915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs3033859 | chr1:105108915-105108916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74718942 | chr1:105108916-105108917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115941113 | chr1:105108979-105108980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs539650158 | chr1:105109001-105109002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4378213 | chr1:105109002-105109003 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs2037115 | chr1:105109052-105109053 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs185470008 | chr1:105109069-105109070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539851067 | chr1:105109084-105109085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564991747 | chr1:105109152-105109153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532289509 | chr1:105109162-105109163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11184210 | chr1:105109163-105109164 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs35890188 | chr1:105109178-105109179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116633206 | chr1:105109180-105109181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs56074665 | chr1:105109195-105109196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144067370 | chr1:105127412-105127413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188547358 | chr1:105127416-105127417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs145969659 | chr1:105127440-105127441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560525068 | chr1:105127512-105127513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533044379 | chr1:105127514-105127515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551663733 | chr1:105127521-105127522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79932255 | chr1:105127535-105127536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546391373 | chr1:105127542-105127543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560527256 | chr1:105127543-105127544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556687310 | chr1:105127565-105127566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369369844 | chr1:105127580-105127581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs180836830 | chr1:105127583-105127584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11584387 | chr1:105127598-105127599 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs77502394 | chr1:105127637-105127638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs11589483 | chr1:105127649-105127650 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs368759208 | chr1:105127672-105127673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs74461261 | chr1:105127740-105127741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs550878380 | chr1:105127774-105127775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112978148 | chr1:105127803-105127804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs9435314 | chr1:105127905-105127906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575631628 | chr1:105127915-105127916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114517457 | chr1:105127944-105127945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139839778 | chr1:105127964-105127965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs72650243 | chr1:105127965-105127966 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs77793358 | chr1:105127967-105127968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:105108800-105109200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr1:105127400-105127800 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr1:105127800-105134800 | Weak transcription | Primary B cells from peripheral blood | blood |
4 | chr1:105134800-105137200 | Enhancers | Primary B cells from peripheral blood | blood |
5 | chr1:105135200-105135400 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr1:105135200-105135600 | Enhancers | GM12878-XiMat | blood |
7 | chr1:105135200-105137000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr1:105135600-105136600 | Weak transcription | H9 Cell Line | embryonic stem cell |
9 | chr1:105136400-105137000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr1:105136600-105137000 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr1:105137000-105144200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr1:105141400-105142000 | Enhancers | Fetal Lung | lung |
13 | chr1:105144200-105144400 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr1:105144400-105145200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr1:105145200-105145400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr1:105145200-105145600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr1:105159400-105159800 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr1:105159600-105161200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr1:105162800-105163600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr1:105163200-105164600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
21 | chr1:105163600-105164200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr1:105164200-105165000 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr1:105165000-105165400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
24 | chr1:105165400-105165600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |